UBS Group’s Gener8 Maritime, Inc. GNRT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-34,353
| Closed | -$194K | – | 8528 |
|
|
2018
Q1 | $194K | Sell |
34,353
-11,434
| -25% | -$68.1K | ﹤0.01% | 4804 |
|
|
2017
Q4 | $303K | Sell |
45,787
-19,512
| -30% | -$93.4K | ﹤0.01% | 4629 |
|
|
2017
Q3 | $294K | Sell |
65,299
-5,506
| -8% | -$27.3K | ﹤0.01% | 4583 |
|
|
2017
Q2 | $403K | Buy |
70,805
+15,148
| +27% | +$81.1K | ﹤0.01% | 4271 |
|
|
2017
Q1 | $316K | Sell |
55,657
-26,189
| -32% | -$130K | ﹤0.01% | 4349 |
|
|
2016
Q4 | $367K | Buy |
81,846
+29,067
| +55% | +$130K | ﹤0.01% | 4338 |
|
|
2016
Q3 | $270K | Sell |
52,779
-57,986
| -52% | -$313K | ﹤0.01% | 4333 |
|
|
2016
Q2 | $709K | Buy |
110,765
+58,224
| +111% | +$413K | ﹤0.01% | 3646 |
|
|
2016
Q1 | $371K | Buy |
52,541
+883
| +2% | +$5.7K | ﹤0.01% | 4008 |
|
|
2015
Q4 | $488K | Sell |
51,658
-48,583
| -48% | -$500K | ﹤0.01% | 3970 |
|
|
2015
Q3 | $1.1M | Buy |
100,241
+93,050
| +1,294% | +$1.22M | ﹤0.01% | 3262 |
|
|
2015
Q2 | $98K | Buy |
+7,191
| New | +$96.7K | ﹤0.01% | 5428 |
|
UBS Group's GNRT Position: Q2 2018 in Review
UBS Group sold out of Gener8 Maritime, Inc. (GNRT) in Q2 2018, closing a stake of 34,353 shares — an estimated $194K sold.
UBS Group first reported a position in GNRT in Q2 2015 and held it in 12 quarters. The position peaked at $1.1M in Q3 2015. 0 funds tracked by Wall St. Rank hold GNRT as of Q2 2018.
- UBS Group reported no remaining Gener8 Maritime, Inc. position as of Q2 2018 after selling out during the quarter.
- UBS Group sold 34,353 Gener8 Maritime, Inc. shares in Q2 2018, an estimated $194K.
- UBS Group first reported a position in Gener8 Maritime, Inc. in Q2 2015 and held it in 12 quarters.
- UBS Group's Gener8 Maritime, Inc. position peaked at $1.1M in Q3 2015.
- 0 funds tracked by Wall St. Rank held Gener8 Maritime, Inc. as of Q2 2018.
Based on UBS Group's 13F filing for Q2 2018, filed 14 Aug 2018.